{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:02:07Z","timestamp":1767916927346,"version":"3.49.0"},"reference-count":45,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2001,12,24]],"date-time":"2001-12-24T00:00:00Z","timestamp":1009152000000},"content-version":"vor","delay-in-days":692,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2000,2]]},"abstract":"<jats:sec><jats:title>Background:<\/jats:title><jats:p> <jats:italic>Helicobacter pylori<\/jats:italic> infection and NSAID usage are considered to be independent risk factors for gastric ulcer (GU). Whether they interact to influence the risk of bleeding in GU is unclear.<\/jats:p><\/jats:sec><jats:sec><jats:title>Aim:<\/jats:title><jats:p>To determine the prevalence of <jats:italic>H.\u2003pylori<\/jats:italic> infection and NSAID ingestion in a group of patients with GU and determine their roles in bleeding and non\u2010bleeding GU.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods and results:<\/jats:title><jats:p>From January 1993 to June 1996, a total of 217 GU patients (150 male, 67 female, median age 61 years, range 26\u201394) were eligible for the study. Eighty\u2010five per cent were <jats:italic>H.\u2003pylori<\/jats:italic>\u2010positive and 15% were <jats:italic>H. pylori<\/jats:italic>\u2010negative. NSAID usage within 4\u2003weeks prior to endoscopy was present in 30%, more in the <jats:italic>H.\u2003pylori<\/jats:italic>\u2010negative than <jats:italic>H.\u2003pylori<\/jats:italic>\u2010positive patients (59% vs. 25% <jats:italic>P<\/jats:italic>\u2003=\u20030.0002). Aspirin was most commonly used (43%). One hundred patients bled from GU (69 male, 31 female, mean age 67 years, range 26\u201394) and 117 did not (81 male, 36 female, mean age 57 years, range 28\u201386). Univariate logistic regression showed that advanced age (\u2265\u200365\u2003years) and NSAID usage carried an increased risk of bleeding GU (odds ratio 3.4 and 6.8, respectively) while <jats:italic>H.\u2003pylori<\/jats:italic> infection alone was not associated with additional risk (OR\u2003=\u20030.8). However, when three variables were considered jointly in a multiple logistic regression, the OR associated with <jats:italic>H.\u2003pylori<\/jats:italic> infection increased to 2.4, suggesting that in the presence of NSAIDs and advanced age, <jats:italic>H.\u2003pylori<\/jats:italic> also increases the risk of bleeding GU, indicating an interaction between the variables.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion:<\/jats:title><jats:p>NSAID usage and advanced age are risk factors for bleeding GU, whereas <jats:italic>H.\u2003pylori<\/jats:italic> infection by itself is not. In the presence of NSAIDs and advanced age, an increased risk of bleeding GU with <jats:italic>H.\u2003pylori<\/jats:italic> is observed, indicating the possibility of an interaction between these factors.<\/jats:p><\/jats:sec>","DOI":"10.1046\/j.1365-2036.2000.00679.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T03:40:52Z","timestamp":1047354052000},"page":"203-209","source":"Crossref","is-referenced-by-count":40,"title":["Non\u2010steroidal anti\u2010inflammatory drugs, <i>Helicobacter pylori<\/i> and bleeding gastric ulcer"],"prefix":"10.1111","volume":"14","author":[{"family":"Ng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Fock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Khor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Teo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Sim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Machin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2001,12,24]]},"reference":[{"key":"e_1_2_5_2_2","first-page":"268","article-title":"Campylobacter pylori, NSAIDs and smoking: risk factors for peptic ulcer disease","volume":"841","author":"Martin DF","year":"1989","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(93)90153-G"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.34.5.580"},{"key":"e_1_2_5_5_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.36.3.334"},{"key":"e_1_2_5_6_2","first-page":"203","article-title":"Helicobacter pylori infection and development of gastric or duodenal ulcer in arthritic patients receiving chronic NSAID therapy","volume":"89","author":"Kim JG","year":"1994","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.33.12.1608"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(97)04523-6"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199803123381105"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(93)90952-9"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(86)92927-2"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-114-4-257"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-115-10-787"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(94)91843-0"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.311.6996.22"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.41.4.459"},{"key":"e_1_2_5_17_2","first-page":"A165","article-title":"Helicobacter pylori, NSAIDs and the risk of peptic ulcer bleeding \u2013 a prospective case\u2010control study with matched pairs","volume":"110","author":"Labenz J","year":"1996","journal-title":"Gastroenterology"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-199710000-00006"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000658-196512000-00005"},{"key":"e_1_2_5_20_2","unstructured":"CampbellMJ&MachinD.Medical Statistics: A Commonsense Approach. Chichester: Wiley 1999: 109\u201313."},{"key":"e_1_2_5_21_2","first-page":"496","article-title":"A comparison of clinical and endoscopic features of bleeding and non\u2010bleeding peptic ulcer in Singapore","volume":"25","author":"Chong YY","year":"1996","journal-title":"Ann Acad Med Singapore"},{"key":"e_1_2_5_22_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.27.8.929"},{"key":"e_1_2_5_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(89)80051-4"},{"key":"e_1_2_5_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(89)80063-0"},{"key":"e_1_2_5_25_2","doi-asserted-by":"publisher","DOI":"10.1159\/000199898"},{"key":"e_1_2_5_26_2","first-page":"1398","article-title":"Non\u2010steroidal anti\u2010inflammatory drug\u2010associated gastric ulcers do not require Helicobacter pylori for their development","volume":"87","author":"Laine L","year":"1992","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_5_27_2","first-page":"A113","article-title":"The prevalence of Helicobacter pylori in patients with bleeding ulcers","volume":"110","author":"Garcia\u2010Carrasquillo RJ","year":"1996","journal-title":"Gastroenterology"},{"key":"e_1_2_5_28_2","first-page":"769","article-title":"Helicobacter pylori and acute bleeding peptic ulcer","volume":"7","author":"Henriksson AE","year":"1995","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"e_1_2_5_29_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.297.6659.1311"},{"key":"e_1_2_5_30_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.32.7.730"},{"key":"e_1_2_5_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(91)90744-A"},{"key":"e_1_2_5_32_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-1005433"},{"key":"e_1_2_5_33_2","first-page":"A5","article-title":"Non\u2010steroidal anti\u2010inflammatory drugs, aspirin and Helicobacter pylori as risk factors for bleeding peptic ulcer","volume":"41","author":"Hawkey GM","year":"1997","journal-title":"Gut"},{"key":"e_1_2_5_34_2","doi-asserted-by":"publisher","DOI":"10.1152\/ajpcell.1990.259.3.C462"},{"key":"e_1_2_5_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(99)70120-4"},{"key":"e_1_2_5_36_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.1995.tb00361.x"},{"key":"e_1_2_5_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(98)70474-3"},{"key":"e_1_2_5_38_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1996.726118000.x"},{"key":"e_1_2_5_39_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.35.5.611"},{"key":"e_1_2_5_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(92)91703-7"},{"key":"e_1_2_5_41_2","first-page":"A66","article-title":"Adaptation of gastric epithelium to injury is independent of neuronal and humoral factors but has a TGF alpha dependent component","volume":"108","author":"Doljanin K","year":"1995","journal-title":"Gastroenterology"},{"key":"e_1_2_5_42_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.1997.00222.x"},{"key":"e_1_2_5_43_2","first-page":"103","article-title":"Molecular mechanisms of ulcer healing \u2013 role of growth factors, angiogenesis and signal transduction pathways. Interference by NSAIDs and H. pylori with these mechanisms impairs ulcer healing","volume":"95","author":"Tarnawski A","year":"1998","journal-title":"Jap J Gastroenterol"},{"key":"e_1_2_5_44_2","first-page":"A192","article-title":"H. pylori infection increases the risk of non\u2010steroidal anti\u2010inflammatory drug (NSAID)\u2010induced gastro\u2010duodenal ulceration","volume":"116","author":"Huang JQ","year":"1999","journal-title":"Gastroenterology"},{"key":"e_1_2_5_45_2","first-page":"223","article-title":"Misoprostol and ranitidine in the prevention of NSAID\u2010induced ulcer: a prospective, double\u2010blind multicenter study","volume":"2","author":"Raskin JB","year":"1996","journal-title":"Am J Gastroenterol"},{"key":"e_1_2_5_46_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199605303342204"}],"container-title":["Alimentary Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2036.2000.00679.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2036.2000.00679.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2036.2000.00679.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T07:01:06Z","timestamp":1697439666000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2036.2000.00679.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,2]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2000,2]]}},"alternative-id":["10.1046\/j.1365-2036.2000.00679.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2036.2000.00679.x","archive":["Portico"],"relation":{},"ISSN":["0269-2813","1365-2036"],"issn-type":[{"value":"0269-2813","type":"print"},{"value":"1365-2036","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,2]]}}}